Abstract
The Thomsen-Friedenreich antigen, a carcinoma-associated disaccharide involved in carcinoma cell homotypic aggregation and increased metastatic potential, has clinical value as a prognostic indicator and a marker of metastasized cells. Hence, it can reasonably be predicted that antigen-binding macromolecules are valuable clinical invivo diagnostic/therapeutic targeting agents. Recently, we have selected first-generation antigen-binding peptides from a random peptide bacteriophage display library and have applied combinatorial affinity maturation to select functionally-maturated peptides, which target cultured carcinoma cells and inhibit carcinoma cell aggregation. In the current study we hypothesize that a targeted search of sequence space surrounding the antigen-binding consensus sequence will select unpredictable amino acid sequences in the non-consensus portions of the peptides, leading to increased affinity for the carbohydrate and greater solubility in physiological buffers. This comprehensive in vitro analysis demonstrates that preferential evolution of the amino-terminal sequence of the peptides occurred, which correlated, in structure/function studies, with the acquisition of maturated function. The maturated peptides are more soluble than the earlier peptides. Studies of peptide binding to the disaccharide indicate that two maturated peptides (P-30-1, F03) have higher affinity for the antigen and bind with higher intensity to the surface of cultured human carcinoma cells than the first-generation peptides. The results support our hypothesis that affinity maturation can improve carbohydrate binding by peptides and have theoretical importance as the first report of maturation of carbohydrate-binding affinity in a small, soluble peptide.
Similar content being viewed by others
References
Marx, J., Cancer research. New insights into metastasis, Science, 294(5541) (2001) 281–282.
Alper, J., Searching for medicine's sweet spot, Science, 291(5512) (2001) 2338–2343.
Brockhausen, I., Schutzbach, J. and Kuhns, W., Glycoproteins and their relationship to human disease, Acta Anatomica, 161(1–4) (1998) 36–78.
Luzzi, K. J., et al., Multistep nature of metastatic inefficiency: Dormancy of solitary cells after successful extravasation and limited survival of early micrometastases, Amer. J. Pathol., 153(3) (1998) 865–873.
Updyke, T. V. and Nicolson, G. L., Malignant melanoma cell lines selected in vitro for increased homotypic adhesion properties have increased experimental metastatic potential, Clin. Exper. Metastasis, 4(4) (1986) 273–284.
Lotan, R. and Raz, A., Low colony formation in vivo and in culture as exhibited by metastatic melanoma cells selected for reduced homotypic aggregation, Cancer Res., 43(5) (1983) 2088–2093.
Meromsky, L., Lotan, R. and Raz, A., Implications of endogenous tumor cell surface lectins as mediators of cellular interactions and lung colonization, Cancer Res., 46(10) (1986) 5270–5275.
Saiki, I., et al., Characterization of the invasive and metastatic phenotype in human renal cell carcinoma, Clin. Exper. Metastasis, 9(6) (1991) 551–566.
Al-Mehdi, A. B., et al., Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: A new model for metastasis, Nature Medicine, 6(1) (2000) 100–102.
Springer, G. F. and Desai, P. R., Cross-reacting carcinoma-associated antigens with blood group and precursor specificities, Transplantation Proceedings, 9(1) (1977) 1105–1111.
Springer, G. F., et al., Proposed molecular basis of murine tumor cell-hepatocyte interaction, J. Biol. Chem., 258(9) (1983) 5702–5706.
Springer, G. F., Desai, P. R. and Banatwala, I., Blood group MN antigens and precursors in normal and malignant human breast glandular tissue, J. National Cancer Institute, 54(2) (1975) 335–339.
Wolf, M. F., et al., Increased expression of Thomsen-Friedenreich antigens during tumor progression in breast cancer patients, Tumour Biology, 9(4) (1988) 190–194.
Khaldoyanidi, S. K., et al., MDA-MB-435 human breast carcinoma cell homo-and heterotypic adhesion under flow conditions is mediated in part by Thomsen-Friedenreich antigengalectin-3 interactions, J. Biol. Chem., 278(6) (2003) 4127–4134.
Glinsky, V. V., et al., The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium, Cancer Res., 61(12) (2001) 4851–4857.
Glinsky, V. V., et al., Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on beta-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells, Cancer Res., 60(10) (2000) 2584–2588.
Kasai, K. and Hirabayashi, J., Galectins: A family of animal lectins that decipher glycocodes, J. Biochem., 119(1) (1996) 1–8.
Matarrese, P., et al., Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties, Internat. J. Cancer, 85(4) (2000) 545–554.
Baldus, S. E., et al., Coexpression of MUC1 mucin peptide core and the Thomsen-Friedenreich antigen in colorectal neoplasms, Cancer, 82(6) (1998) 1019–1027.
Baldus, S. E., et al., Thomsen-Friedenreich antigen presents as a prognostic factor in colorectal carcinoma: A clinicopathologic study of 264 patients, Cancer, 88(7) (2000) 1536–1543.
Peletskaya, E. N., et al., Characterization of peptides that bind the tumor-associated Thomsen-Friedenreich antigen selected from bacteriophage display libraries, J. Molecular Biol., 270(3) (1997) 374–384.
Peletskaya, E. N., et al., Identification of peptide sequences that bind the Thomsen-Friedenreich cancer-associated glycoantigen from bacteriophage peptide display libraries, Molecular Diversity, 2(1–2) (1996) 13–18.
Rittenhouse-Diakun, K., et al., Development and characterization of monoclonal antibody to T-antigen: (gal beta1-3GalNAc-alpha-O), Hybridoma, 17(2) (1998) 165–173.
Houghten, R. A., et al., Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery, Nature, 354(6348) (1991) 84–86.
Rademann, J. and Jung, G., Techview: Drug discovery. Integrating combinatorial synthesis and bioassays, Science, 287(5460) (2000) 1947–1948.
Ryu, D. D. and Nam, D. H., Recent progress in biomolecular engineering, Biotechnology Progress, 16(1) (2000) 2–16.
Kay, B. K., et al., Convergent evolution with combinatorial peptides, FEBS Letters, 480(1) (2000) 55–62.
Scott, J. K. and Smith, G. P., Searching for peptide ligands with an epitope library, Science, 249(4967) (1990) 386–390.
Siebert, H. C., et al., Analysis of protein-carbohydrate interaction at the lower size limit of the protein part (15-mer peptide) by NMR spectroscopy, electrospray ionization mass spectrometry, and molecular modeling, Biochemistry, 41(30) (2002) 9707–9717.
Landon, L. A., et al., Combinatorial evolution of high affinity peptides that bind to the Thomsen-Friedenreich carcinoma antigen, J. Prot. Chem., 22(2) (2003) 193–204.
Smith, G. P. and Yu, J., In search of dark horses: Affinity maturation of phage-displayed ligands, Molecular Diversity, 2(1–2) (1996) 2–4.
Foote, J. and Eisen, H. N., Breaking the affinity ceiling for antibodies and T cell receptors, Proceedings of the National Academy of Sciences of the United States of America, 97(20) (2000) 10679–10681.
Yu, J. and Smith, G. P., Affinity maturation of phage-displayed peptide ligands, Methods in Enzymology, 267 (1996) 3–27.
Kirschner, K. N. W. R. J., Solvent interactions determine carbohydrate conformation, Proceedings of the National Academy of Sciences of the United States of America, 98(19) (2001) 10541–10545.
Smith, G. P. and Petrenko, V. A., Phage display, Chemical Reviews, 97(2) (1997) 391–410.
Lotan, R., et al., The purification, composition, and specificity of the anti-T lectin from peanut (Arachis hypogaea), J. Biol. Chem. 250(21) (1975) 8518–8523.
Pereira, M. E., et al., Immunochemical studies on the specificity of the peanut (Arachis hypogaea) agglutinin, Carbohydrate Research, 51(1) (1976) 107–118.
Haas, S. J. and Smith, G. P., Rapid sequencing of viral DNA from filamentous bacteriophage, Biotechniques, 15(3) (1993) 422–424, 426–428, 431.
Pietrokovski, S., Searching databases of conserved sequence regions by aligning protein multiple-alignments (erratum appears in Nucleic Acids Res. 1996 Nov. 1 24(21) 4372.), Nucleic Acids Res., 24(19) (1996) 3836–3845.
Schneider, T. D. and Stephens, R. M., Sequence logos: A new way to display consensus sequences, Nucleic Acids Res., 18(20) (1990) 6097–6100.
Henikoff, S., et al., Automated construction and graphical presentation of protein blocks from unaligned sequences, Gene., 163(2) (1995) GC17–GC26.
Schneider, T. D., Evolution of biological information, Nucleic Acids Res., 28(14) (2000) 2794–2799.
Spiro, R. G., Studies on fetuin, a glycoprotein of fetal serum. I. Isolation, chemical composition, and physicochemical properties, J. Biol. Chem., 235(10) (1960) 2860.
Edge, A. S. and Spiro, R. G., Presence of an O-glycosidically linked hexasaccharide in fetuin, J. Biol. Chem., 262(33) (1987) 16135–16141.
Panchuk-Voloshina, N., et al., Alexa dyes, a series of new fluorescent dyes that yield exceptionally bright, photostable conjugates, Journal of Histochemistry and Cytochemistry, 47(9) (1999) 1179–1188.
Triantafilou, K., Triantafilou, M. and Fernandez, N., Lipopolysaccharide (LPS) labeled with Alexa 488 hydrazide as a novel probe for LPS binding studies, Cytometry, 41(4) (2000) 316–320.
Denzin, L. K. and Voss, E.W., Construction, characterization, and mutagenesis of an anti-fluorescein single chain antibody idiotype family, J. Biol. Chem., 267(13) (1992) 8925–8931.
Gudgin Templeton, E. F. and Ware, W. R., Charge transfer between fluorescein and tryptophan as a possible interaction in the binding of fluorescein to anti-fluorescein antibody, Molecular Immunology, 22(1) (2985) 45–55.
Mummert, M. E. and Voss, E. W., Effects of secondary forces on the ligand binding properties and variable domain conformations of a monoclonal anti-fluorescyl antibody, Molecular Immunology, 33(13) (1996) 1067–1077.
Mummert, M. E. and Voss, E. W., Effects of secondary forces on the ligand binding and conformational state of antifluorescein monoclonal antibody 9-40, Biochemistry, 36(39) (1997) 11918–11922.
Watt, R. M. and Voss, E.W., Mechanism of quenching of fluorescein by anti-fluorescein IgG antibodies, Immunochemistry, 14(7) (1977) 533–551.
Kim, C., Paulus, B. F. and Wold, M. S., Interactions of human replication protein A with oligonucleotides, Biochemistry, 33(47) (1994) 14197–14206.
Schmidt, C. M., et al., Characterization of spontaneous metastasis in an aggressive breast carcinoma model using flow cytometry, Clin. Exper. Metastasis, 17(6) (1999) 537–544.
Fidler, I. J., Biological behavior of malignant melanoma cells correlated to their survival in vivo, Cancer Res., 35 (1975) 218–224.
Soisson, S. M., et al., Structural basis for ligand-regulated oligomerization of AraC, Science, 276(5311) (1997) 421–425.
Samanta, U., Pal, D. and Chakrabarti, P., Environment of tryptophan side chains in proteins, Proteins, 38(3) (2000) 288–300.
Banerjee, R., et al., Conformation, protein-carbohydrate interactions and a novel subunit association in the refined structure of peanut lectin-lactose complex, J. Molecular Biol., 259(2) (1996) 281–296.
Siebert, H. C., et al., Role of aromatic amino acids in carbohydrate binding of plant lectins: Laser photo chemically induced dynamic nuclear polarization study of hevein domain-containing lectins, Proteins, 28(2) (1997) 268–284.
Simpson, P. J., et al., The structural basis for the ligand specificity of family 2 carbohydrate-binding modules, J. Biol. Chem., 275(52) (2000) 41137–41142.
Ponyi, T., et al., Trp22, Trp24, and Tyr8 play a pivotal role in the binding of the family 10 cellulose-binding module from Pseudomonas xylanase A to insoluble ligands, Biochemistry, 39(5) (2000) 985–991.
Luo, P., et al., A molecular basis for functional peptide mimicry of a carbohydrate antigen, J. Biol. Chem., 275(21) (2000) 16146–16154.
Sears, P. and Wong, C. H., Intervention of carbohydrate recognition by proteins and nucleic acids, Proceedings of the National Academy of Sciences of the United States of America, 93(22) (1996) 12086–12093.
Jimbo, A. and Matsumoto, I., Involvement of a tyrosyl residue in the interaction of peanut lectin with lactose, J. Biochem., 91(3) (1982) 945–951.
Rao, V. S., Lam, K. and Qasba, P. K., Architecture of the sugar binding sites in carbohydrate binding proteins — A computer modeling study, Internat. J. Biol. Macromolecules, 23(4) (1998) 295–307.
Pratt, W., 'The Entry, Distribution, and Elimination of Drugs', in W. Pratt and P. Taylor (eds), Principles of Drug Action. The Basis of Pharmacology, Churchill Livingstone, New York, (1990) pp. 201–296.
De Kroon, A. I., et al., The role of charge and hydrophobicity in peptide-lipid interaction: A comparative study based on tryptophan fluorescence measurements combined with the use of aqueous and hydrophobic quenchers, Biochemistry, 29(36) (1990) 8229–8240.
Jain, R. K., Delivery of novel therapeutic agents in tumors: Physiological barriers and strategies, J. National Cancer Institute, 81(8) (1989) 570–576.
Komissarov, A. A. and Deutscher, S. L., Thermodynamics of Fab-ssDNA interactions: Contribution of heavy chain complementarity determining region 3, Biochemistry, 38(44) (1999) 14631–14637.
Komissarov, A. A., et al., Equilibrium binding studies of recombinant anti-single-stranded DNA Fab. Role of heavy chain complementarity-determining regions, J. Biol. Chem., 271(21) (1996) 12241–12246.
Yelton, D. E., et al., Affinity maturation of the BR96 anti-carcinoma antibody by codon-based mutagenesis, J. Immunology, 155(4) (1995) 1994–2004.
Boder, E. T., Midelfort, K. S. and Wittrup, K. D., Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity, Proceedings of the National Academy of Sciences of the United States of America, 97(20) (2000) 10701–10705.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Landon, L.A., Zou, J. & Deutscher, S.L. Effective combinatorial strategy to increase affinity of carbohydrate binding by peptides. Mol Divers 8, 35–50 (2004). https://doi.org/10.1023/B:MODI.0000006897.40575.41
Issue Date:
DOI: https://doi.org/10.1023/B:MODI.0000006897.40575.41